(Q46009832)

English

Rituximab in refractory and non-refractory myasthenia: a retrospective multicenter study.

scientific article published on 31 August 2012

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/22941747

Rituximab in refractory and non-refractory myasthenia: a retrospective multicenter study. (English)

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/22941747

1 reference

based on heuristic

inferred from title

3

object named as

Arnaud Lacour

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/22941747

Patrick Vermersch

5

object named as

Patrick Vermersch

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/22941747

author name string

Nicolas Collongues

1

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/22941747

Olivier Casez

2

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/22941747

Christine Tranchant

4

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/22941747

Jérôme de Seze

6

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/22941747

Christine Lebrun

7

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/22941747

language of work or name

1 reference

based on heuristic

inferred from title

publication date

31 August 2012

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/22941747

Muscle and Nerve

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/22941747

46

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/22941747

5

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/22941747

687-691

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/22941747

Practice parameter: thymectomy for autoimmune myasthenia gravis (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology

1 reference

https://api.crossref.org/works/10.1002%2FMUS.23412

21 January 2018

Autoimmune myasthenia gravis: emerging clinical and biological heterogeneity

1 reference

https://api.crossref.org/works/10.1002%2FMUS.23412

21 January 2018

Successful treatment of refractory generalized myasthenia gravis with rituximab

1 reference

https://api.crossref.org/works/10.1002%2FMUS.23412

21 January 2018

Allogeneic hematopoietic cell transplantation for refractory myasthenia gravis.

1 reference

https://api.crossref.org/works/10.1002%2FMUS.23412

21 January 2018

Response of patients with refractory myasthenia gravis to rituximab: a retrospective study

1 reference

https://api.crossref.org/works/10.1002%2FMUS.23412

21 January 2018

Rituximab for severe myasthenia gravis--experience from five patients

1 reference

https://api.crossref.org/works/10.1002%2FMUS.23412

21 January 2018

Use and monitoring of low dose rituximab in myasthenia gravis.

1 reference

https://api.crossref.org/works/10.1002%2FMUS.23412

21 January 2018

Myasthenia gravis: recommendations for clinical research standards. Task Force of the Medical Scientific Advisory Board of the Myasthenia Gravis Foundation of America

1 reference

https://api.crossref.org/works/10.1002%2FMUS.23412

21 January 2018

Fatal progressive multifocal leukoencephalopathy in a patient with non-Hodgkin lymphoma treated with rituximab

1 reference

https://api.crossref.org/works/10.1002%2FMUS.23412

21 January 2018

Progressive multifocal leukoencephalopathy in chronic lymphocytic leukemia: a report of three cases and review of the literature.

1 reference

https://api.crossref.org/works/10.1002%2FMUS.23412

21 January 2018

Progressive multifocal leukoencephalopathy after rituximab therapy in HIV-negative patients: a report of 57 cases from the Research on Adverse Drug Events and Reports project

1 reference

https://api.crossref.org/works/10.1002%2FMUS.23412

21 January 2018

The use of rituximab in myasthenia gravis and Lambert-Eaton myasthenic syndrome.

1 reference

https://api.crossref.org/works/10.1002%2FMUS.23412

21 January 2018

Rituximab in the management of refractory myasthenia gravis

1 reference

https://api.crossref.org/works/10.1002%2FMUS.23412

21 January 2018

Identifiers

10.1002/MUS.23412

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/22941747

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/22941747

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46009832&oldid=1744384577"